Episode
Endometrial Cancer — Microlearning Activity 3: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer
- Podcast
- Gynecologic Oncology Update
- Published
- Sep 11, 2026
- Duration seconds
- 1204
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/gynecologic-oncology-update-612940/episodes/endometrial-cancer-microlearning-activity-3-proceedings-from-an-independent-satellite-symposium-during-the-sgo-annual-meeting-on-women-s-cancer/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/gynecologic-oncology-update-612940/endometrial-cancer-microlearning-activity-3-proceedings-from-an-independent-satellite-symposium-during-the-sgo-annual-meeting-on-women-s-cancer.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Featuring perspectives from Dr Floor J Backes, Dr Matthew A Powell and Dr Ritu Salani, moderated by Dr Salani, including the following topics: Case: A woman in her late 60s with recurrence of metastatic estrogen receptor-positive endometrial cancer enrolls in a trial of CDK4/6 inhibition with an aromatase inhibitor 1 year into maintenance dostarlimab after carboplatin/paclitaxel/dostarlimab and has no evidence of disease 3 years later (0:00) Adding a PARP inhibitor to immunotherapy and chemotherapy: The RUBY Part 2 and DUO-E trials (10:03) CME information and select publications